Rothschild & Co Asset Management US’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
LP
FCM
Rothschild & Co Asset Management US's AGN Position: Q3 2019 in Review
Rothschild & Co Asset Management US sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 211,510 shares — an estimated $35.4M sold.
Rothschild & Co Asset Management US first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $54.4M in Q3 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.
- Rothschild & Co Asset Management US reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
- Rothschild & Co Asset Management US sold 211,510 Allergan plc shares in Q3 2019, an estimated $35.4M.
- Rothschild & Co Asset Management US first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
- Rothschild & Co Asset Management US's Allergan plc position peaked at $54.4M in Q3 2017.
- 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.
Based on Rothschild & Co Asset Management US's 13F filing for Q3 2019, filed 8 Nov 2019.